Join the HIV Infection group to help and get support from people like you.
HIV Infection News
Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS
U.S. Cuts to HIV Aid Could Lead to 4 Million Deaths, U.N. Warns
FRIDAY, July 11, 2025 — Global deaths from AIDS have dropped to their lowest levels in more than 30 years, in part due to efforts to fight HIV. But U.S. funding cuts could soon reverse that progress, ...
From Transgender Care To Vaping: Key Takeaways From SCOTUS 2025 Term
FRIDAY, June 27, 2025 — From allowing states to ban gender-transition care and sales of flavored vapes to minors to rolling back the landmark Clean Air Act, the U.S. Supreme Court had a consequential ...
FDA Approves Yeztugo (lenacapavir) as the First and Only HIV Prevention Option Offering 6 Months of Protection
FOSTER CITY, Calif.--(BUSINESS WIRE) June 18, 2025 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo (lenacapavir)—the co...
FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk
FRIDAY, June 20, 2025 – The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as preexposure prophylaxis (PrEP) to reduce the risk for...
HIV Drug, Lamivudine, Potentially Effective Against Diabetic Eye Disease
FRIDAY, June 20, 2025 — A cheap HIV drug might be able to help people with diabetes reverse a complication that can lead to blindness, a new small-scale study says. The drug, lamivudine, appears to i...
HIV Drug, Lamivudine, Potentially Effective Against Diabetic Eye Disease
FRIDAY, June 20, 2025 — A cheap HIV drug might be able to help people with diabetes reverse a complication that can lead to blindness, a new small-scale study says. The drug, lamivudine, appears to i...
Anal Cancer Screening Cost-Effective for HIV+ Men Who Have Sex With Men ≥35 Years of Age
TUESDAY, June 17, 2025 – For men who have sex with men (MSM) with HIV, aged 35 years or older, anal cancer screening is cost-effective, according to a study published online June 17 in the Annals of...
More Than 460 CDC Workers Reinstated After Layoffs
FRIDAY, June 13, 2025 — More than 460 laid-off employees at the U.S. Centers for Disease Control and Prevention (CDC) are being rehired, officials said June 11. The reinstatement notices went out t...
Long-Lasting HIV Prevention Shot Headed Toward Approval
FRIDAY, June 6, 2025 — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot — lenacapavir — would be given t...
Jail Time Increases A Person's Risk of Death
THURSDAY, June 5, 2025 — Jail time has a huge effect on both an individual’s and a community’s long-term health, even after their release, a new study says. People serving time are 39% more likely to ...
Initiation of HIV PrEP in Young Adults Rose in Recent Years
TUESDAY, June 3, 2025 – Dispensing and initiation of HIV preexposure prophylaxis (PrEP) among young adults increased from 2016 through 2023, according to a study published online May 9 in...
Eight Times More Young Adults Take Meds To Protect Against HIV Infection
FRIDAY, May 30, 2025 — Eight times more young Americans are taking antiretroviral meds to protect them from HIV infection than a decade ago, a new study says. About 208 of every 100,000 U.S. young a...
ACP Issues Clinical Guideline for Statin Use in Persons With HIV
THURSDAY, May 29, 2025 – In a clinical guideline issued by the American College of Physicians and published online May 27 in the Annals of Internal Medicine, recommendations are presented for the...
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 – Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a significantly lower...
HIV Pills Might Prevent Alzheimer's
TUESDAY, May 13, 2025 — Drugs that battle HIV and hepatitis B might be able to help people avoid Alzheimer’s disease, a new study says. Nucleoside reverse transcriptase inhibitors (NRTIs) are used to ...
Further information
Related condition support groups
Pre-Exposure Prophylaxis, Viral Infection
Related drug support groups
Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Genvoya, Triumeq